Cellestia Biotech picks up Series B

Cellestia Biotech AG, a clinical-stage biopharma company, has secured CHF 20 million in Series B funding.

Cellestia Biotech AG, a clinical-stage biopharma company, has secured CHF 20 million in Series B funding. The investors included FC Capital and Partners Investment.

Source: Press Release